Loading...
Sotera Health Company
SHC•NASDAQ
Healthcare
Medical - Diagnostics & Research
$12.30
$0.19(1.57%)
Sotera Health Company (SHC) Financial Performance & Income Statement Overview
Review Sotera Health Company’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
4.88%
↑ 4.88%
Operating Income Growth
7.57%
↑ 7.57%
Net Income Growth
-13.58%
↓ 13.58%
Operating Cash Flow Growth
251.74%
↑ 251.74%
Operating Margin
28.001%
↑ 28.001%
Gross Margin
53.78%
↑ 53.78%
Net Profit Margin
2.24%
↑ 2.24%
ROE
5.80%
↑ 5.80%
ROIC
10.79%
↑ 10.79%
Sotera Health Company (SHC) Income Statement & Financial Overview
Review Sotera Health Company's (SHC) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $290.20M | $285.47M | $276.59M | $248.18M |
| Cost of Revenue | $125.84M | $127.44M | $139.22M | $136.79M |
| Gross Profit | $164.37M | $158.02M | $137.37M | $111.38M |
| Gross Profit Ratio | $0.57 | $0.55 | $0.50 | $0.45 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $61.84M | $62.009M | $52.16M | $51.82M |
| Operating Expenses | $77.22M | $77.52M | $52.16M | $51.82M |
| Total Costs & Expenses | $203.06M | $204.96M | $191.38M | $188.61M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $40.96M | $41.57M | $40.39M | $41.77M |
| Depreciation & Amortization | $39.71M | $43.06M | $40.47M | $41.07M |
| EBITDA | $126.24M | $122.85M | $87.45M | $95.12M |
| EBITDA Ratio | $0.43 | $0.43 | $0.32 | $0.38 |
| Operating Income | $87.15M | $80.51M | $85.21M | $59.57M |
| Operating Income Ratio | $0.30 | $0.28 | $0.31 | $0.24 |
| Other Income/Expenses (Net) | -$42.18M | -$37.75M | -$61.66M | -$42.16M |
| Income Before Tax | $44.96M | $42.75M | $15.14M | $11.01M |
| Income Before Tax Ratio | $0.15 | $0.15 | $0.05 | $0.04 |
| Income Tax Expense | $32.64M | $25.76M | $6.39M | $4.69M |
| Net Income | $12.32M | $16.99M | $8.75M | $6.32M |
| Net Income Ratio | $0.04 | $0.06 | $0.03 | $0.03 |
| EPS | $0.04 | $0.06 | $0.03 | $0.02 |
| Diluted EPS | $0.04 | $0.06 | $0.03 | $0.02 |
| Weighted Avg Shares Outstanding | $283.26M | $283.06M | $282.89M | $281.91M |
| Weighted Avg Shares Outstanding (Diluted) | $285.82M | $285.56M | $284.54M | $284.06M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan